Tag: diseases
CIRC Announces 2023 Annual Results
HONG KONG, Apr 17, 2024 - (ACN Newswire) - China Isotope & Radiation Corporation (“CIRC” or the “Company” , together with its subsidiaries, the “Group”;...
Breaking News
Viruses Finally Reveal Their Complex Social Life | Quanta Magazine
IntroductionEver since viruses came to light in the late 1800s, scientists have set them apart from the rest of life. Viruses were far smaller...
Quantum News Briefs: April 5, 2024: Classiq and Quantum Intelligence Corp (QIC, Korea) Partner On Quantum Accelerated Drug Development; Keyfactor’s New Command SaaS Lite...
By Kenna Hughes-Castleberry posted 05 Apr 2024
Quantum News Briefs: April 5, 2024: Press release summaries below:
Classiq and...
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French...
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French...
Environmental DNA Is Everywhere. Scientists Are Gathering It All.
In the late 1980s, at a federal research facility in Pensacola, Florida, Tamar Barkay used mud in a way that proved revolutionary in a...
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...
A New Treatment Rejuvenates Aging Immune Systems in Elderly Mice
Our immune system is like a well-trained brigade.Each unit has a unique specialty. Some cells directly kill invading foes; others release protein “markers” to...
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights...
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights...
Eisai’s Brain Health Self-Check Tool “NouKNOW” is Certified as “ME-BYO BRAND” by Kanagawa Prefecture
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that “NouKNOW®”, Eisai’s self-check tool for brain health, was certified as...
Eisai’s Brain Health Self-Check Tool “NouKNOW” is Certified as “ME-BYO BRAND” by Kanagawa Prefecture
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that “NouKNOW®”, Eisai’s self-check tool for brain health, was certified as...
Sino Biopharm (1177.HK) Announces 2023 Annual Results
HONG KONG, Mar 29, 2024 - (ACN Newswire) - Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a...
Latest Intelligence
